Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 88 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
871 12.8 months Metastatic colorectal cancer 3 Chemotherapy
The University of Texas M.D. Anderson Cancer Center United States 6/2004
Treatment Details: Patients: This Phase II study involved 22 patients with metastatic colorectal cancer. All patients had been previously treated with 5-FU. Treatment: Treatment consisted of the chemother
 
872 12.8 months Relapsed or refractory mantle cell lymphoma 4 Biologic therapy
Johannes Gutenberg-University Germany 8/2009
Treatment Details: Patients: This phase 3 study involved 54 previously treated, relapsed or refractory mantle cell lymphoma patients. The median patient age was 68 years and 85% were male. Treatment: Pat
 
873 12.8 months Advanced malignant pleural mesothelioma 4 Chemotherapy
Memorial Sloan Kettering Cancer Center United States 9/2014
Treatment Details: Patients: This phase 2 study involved advanced malignant pleural mesothelioma patients who had not received prior chemotherapy and who were divided into two separate treatment groups. Grou
 
874 12.7 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
David Geffen School of Medicine at University of California at Los Angeles United States 10/2013
Treatment Details: Patients: This phase 2 study involved 45 elderly and/or frail metastatic colorectal cancer patients. The median patient age was 79 years and 40% were male. Treatment: Patients received
 
875 12.7 months Advanced melanoma 4 Biologic therapy
Yale University School of Medicine United States 5/2011
Treatment Details: Patients: This study involved 39 melanoma patients who had not previously received chemotherapy. The average patient age was 64 years and 67% were male. Treatment: Patients were treate
 
876 12.7 months Metastatic breast cancer 4 Biologic therapy
Mayo Clinic United States 12/2012
Treatment Details: Patients: This phase 2 study involved 21 female previously treated metastatic breast cancer patients. The median patient age was 58 years. Treatment: Patients were treated with the bio
 
877 12.7 months Epithelial ovarian cancer, primary fallopian tube cancer, primary peritoneal cancer 5 Chemotherapy
Università Milano-Bicocca Italy 11/2012
Treatment Details: Patients: This phase 3 study involved epithelial ovarian, primary fallopian tube, and primary peritoneal cancer patients previously treated with platinum-based chemotherapy who were divided
 
878 12.7 months metastatic urothelial cancer 5 Chemotherapy
University Hospital Del Mar–Institut Municipal d’Investigacio Medica Spain 2/2012
Treatment Details: Patients: This phase 3 study involved patients with advanced or metastatic urothelial cancer who had not received prior chemotherapy and were divided into two separate treatment groups. Gr
 
879 12.7 months Metastatic Melanoma 5 Biologic therapy
Dana-Farber Cancer Institute United States 11/2014
Treatment Details: Patients: This phase 2 study involved metastatic melanoma patients who were divided into two separate treatment groups. Group A consisted of 123 patients with a median age of 61 years; 69.
 
880 12.7 months metastatic breast cancer 4 Chemotherapy
Texas Oncology United States 8/2005
Treatment Details: Patients: This Phase III study involved 449 women with advanced breast cancer, of whom 394 were assessed. All patients had previously received an anthracycline-containing chemotherapy regi
 
Page 88 of 187  | Previous Page  | Next Page